Table 1.
Baseline characteristics of patients with HCC
| Variable | HCC patients (n=9) |
|---|---|
| Sex | |
| Male | 7 (78.0) |
| Female | 2 (22.0) |
| Pathogenesis | |
| Alcohol | 2 (22.0) |
| HBV | 2 (22.0) |
| HCV | 3 (45.0) |
| Others | 1 (11.0) |
| AFP at diagnosis | |
| <100 ng/mL | 3 (33.0) |
| ≥100 ng/mL | 6 (67.0) |
| PIVKA-II at diagnosis | |
| <40 mAU/mL | 2 (22.0) |
| ≥40 mAU/mL | 7 (78.0) |
| Multiple tumors | |
| Yes | 5 (56.0) |
| No | 4 (44.0) |
| Vascular invasion | |
| Yes | 4 (44.0) |
| No | 5 (56.0) |
| Non-tumor cirrhosis | |
| Yes | 6 (67.0) |
| No | 3 (33.0) |
| ES grade | |
| 1 | - |
| 2 | 1 (11.0) |
| 3 | 6 (67.0) |
| 4 | 2 (22.0) |
| Maximal tumor size | |
| <10 cm | 2 (22.0) |
| ≥10 cm | 7 (78.0) |
Values are presented as number (%).
HCC, Hepatocellular carcinoma, HBV, Hepatitis B virus; HCV, Hepatitis C virus; AFP, alpha fetoprotein; PIVKA-II, Protein induced by vitamin K absence or antagonist-II; ES grade, Edmondson-Steiner grade.